Trademark: 97285043
Word
OQORY
Status Date
Thursday, August 22, 2024
Filing Date
Friday, February 25, 2022
Published for Opposition
Tuesday, January 3, 2023
5 Mesenchymal stem cells for medical purposes for use in the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations for human use, namely, Mesenchymal stem cells for medical or clinical use for the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations featuring Mesenchymal stem cells for the treatment and prevention of infectious diseases, namely, COVID-19 and Coronaviruses
Mar 1, 2022
New Application Entered
Mar 3, 2022
New Application Office Supplied Data Entered
Dec 1, 2022
Approved For Pub - Principal Register
Nov 30, 2022
Assigned To Examiner
Dec 14, 2022
Notification Of Notice Of Publication E-Mailed
Jan 3, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2023
Published For Opposition
Feb 28, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 31, 2023
Sou Teas Extension Received
Jul 31, 2023
Sou Extension 1 Filed
Jul 31, 2023
Sou Extension 1 Granted
Apr 24, 2024
Automatic Update Of Assignment Of Ownership
Aug 22, 2024
Sou Teas Extension Received
Aug 22, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2024
Sou Extension 3 Granted
Aug 23, 2024
Sou Extension 3 Filed
Feb 1, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 30, 2024
Sou Teas Extension Received
Jan 30, 2024
Sou Extension 2 Filed
Jan 30, 2024
Sou Extension 2 Granted
Trademark Alertz updated from USPTO on 2030-01-24
